References

• Brown, T. A., Chorpita, B. F., & Barlow, D. H. J. J. O. A. P. (1998). Structural relationships among dimensions of the DSM‐IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. 107(2), 179.
• Buckner, J. D., Timpano, K. R., Zvolensky, M. J., Sachs‐Ericsson, N., & Schmidt, N. B. (2008). Implications of comorbid alcohol dependence among individuals with social anxiety disorder. Depression Anxiety, 25(12), 1028‐1037.
• Butnoriene, J., Bunevicius, A., Saudargiene, A., Nemeroff, C. B., Norkus, A., Ciceniene, V., & Bunevicius, R. (2015). Metabolic syndrome, major depression, generalized anxiety disorder, and ten‐year all‐cause and cardiovascular mortality in middle aged and elderly patients. International Journal of Cardiology, 190, 360‐366.
• Compton, W. M., Conway, K. P., Stinson, F. S., Colliver, J. D., & Grant, B. F. (2005). Prevalence, correlates, and comorbidity of DSM‐IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66(6), 677‐685.
• Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009). Cannabis and anxiety: a critical review of the evidence. Human Psychopharmacology: Clinical Experimental, 24(7), 515‐523.
• Degenhardt, L., Chiu, W. T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Huang, Y. (2008). Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Medicine, 5(7), e141.
• Degenhardt, L., Ferrari, A. J., Calabria, B., Hall, W. D., Norman, R. E., McGrath, J., Whiteford, H. A. J. P. O. (2013). The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. 8(10), e76635.
• Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet, 379(9810), 55‐70.
• Falk, D. E., Yi, H. y., & Hilton, M. E. (2008). Age of onset and temporal sequencing of lifetime DSM‐IV alcohol use disorders relative to comorbid mood and anxiety disorders. Drug Alcohol Dependence, 94(1‐3), 234‐245.
• Fergusson, D. M., & Woodward, L. J. (2002). Mental health, educational, and social role outcomes of adolescents with depression. Archives of General Psychiatry, 59(3), 225‐ 231.
• Friedrich, M. J. (2017). Depression is the leading cause of disability around the world. JAMA, 317(15), 1517‐1517.
• Glantz, M. D., Anthony, J. C., Berglund, P. A., Degenhardt, L., Dierker, L., Kalaydjian, A., Kessler, R. C. (2009). Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychological Medicine, 39(8), 1365‐1377.
• Grobe, T., Steinmann, S., & Gerr, J. (2011). Veröffentlichungen zum betrieblichen Gesundheitsmanagement der Techniker Krankenkasse. Gesundheitsreport 2011, 26.
• Hafi, S. B. B., Hayat, N., Qureshi, N., Tanzeem, T., Jovindah, S., & Hafeez, H. Comparison of Current Screening for Prevalence of Depression and Anxiety with Standardized Screening Tools I Patient Health Questionnaire‐9 and Generalized Anxiety Disorder‐7 among Adult Inpatients at Shaukat Khanum Memorial Cancer Hospital and Research Centre.
• Morisano, D., Babor, T. F., & Robaina, K. A. (2014). Co‐occurrence of substance use disorders with other psychiatric disorders: Implications for treatment services. Nordic Studies on Alcohol Drugs, 31(1), 5‐25.
• Stein, M. B., & Sareen, J. (2015). Generalized anxiety disorder. New England Journal of Medicine, 373(21), 2059‐2068.
• Swendsen, J. D., Merikangas, K. R., Canino, G. J., Kessler, R. C., Rubio‐Stipec, M., & Angst, J. (1998). The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Comprehensive Psychiatry, 39(4), 176‐184.
• Temple, E. C., Driver, M., & Brown, R. F. (2014). Cannabis use and anxiety: is stress the missing piece of the puzzle? Frontiers in Psychiatry, 5, 57159.
• Wittchen, H.‐U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Faravelli, C. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21(9), 655‐679.
• Woodward, L. J., & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child Adolescent Psychiatry, 40(9), 1086‐1093.
• Zaman, S., Hussain, B., Irfan, S., Khattak, A. Z., & Shaheen, A. (2022). Sociodemographic characteristics and related factors of substance use in Pakistan; a retrospective study. Journal of Substance Use, 1‐6.
• Zimmermann, P., Wittchen, H.‐U., Höfler, M., Pfister, H., Kessler, R. C., & Lieb, R. (2003). Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4‐year community study of adolescents and young adults. Psychological Medicine, 33(7), 1211‐1222.